Our client is an innovation development company dedicated to commercialising medical technologies created within the NHS. Backed by £9 million of investment capital from NVM Private Equity and a private US investor has access to qualified deal flow from its partner NHS innovation organisation Health Enterprise East (HEE). By providing funding at a crucial point in development, they will ensure that novel medical technologies with high potential growth are accelerated through the clinical trial and regulatory approval phases so that they can reach the market as quickly as possible.

Read the rest of entry »